3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
164
Completed
43
Recruiting
40
Not yet recruiting
22
Active not recruiting
10
Withdrawn
7
Terminated
7
Suspended
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Osteosarcoma
1
Drug-Related Side Effects and Adverse Reactions
1
Interventions
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
Biopsy
5
Nivolumab
4
Capecitabine
4
Vincristine
3
Radiosurgery
3
Paclitaxel
3
Irinotecan
3
Fluorouracil
3
Everolimus
3
Docetaxel
3
Dexamethasone
3
Cyclophosphamide
3
Cisplatin
3
Bevacizumab
3
trifluridine tipiracil drug combination
2
spartalizumab
2
pembrolizumab
2
lenvatinib
2
daratumumab
2
Taxes
2
Radiation
2
Prednisone
2
Pemetrexed
2
Oxaliplatin
2
Mitoxantrone
2
Leucovorin
2
Injections
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Suspended
×
apatinib
×
Clear all
NCT04824352
2024-05-14
AIEO
Peking University People's Hospital
Phase 2
Suspended
44 enrolled